<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03815296</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-20T16:35:37+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use</title>
            <author role="aut">
              <persName>
                <forename type="first">Celian</forename>
                <surname>Bertin</surname>
              </persName>
              <email type="md5">114ac354fd081f0b5b286d44aed92b11</email>
              <email type="domain">chu-clermontferrand.fr</email>
              <idno type="idhal" notation="string">celian-bertin</idno>
              <idno type="idhal" notation="numeric">1318562</idno>
              <idno type="halauthorid" notation="string">1459818-1318562</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-2393-7061</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=MifamIcAAAAJ</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/AAG-6322-2021</idno>
              <idno type="IDREF">https://www.idref.fr/24512893X</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/AAG-6322-2021</idno>
              <affiliation ref="#struct-300144"/>
              <affiliation ref="#struct-1063704"/>
              <affiliation ref="#struct-1089760"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Julien</forename>
                <surname>Bezin</surname>
              </persName>
              <email type="md5">8f0884978d348bd621798a5caf01e699</email>
              <email type="domain">u-bordeaux.fr</email>
              <idno type="idhal" notation="numeric">1670226</idno>
              <idno type="halauthorid" notation="string">1176113-1670226</idno>
              <idno type="IDREF">https://www.idref.fr/181595710</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-2568-1928</idno>
              <affiliation ref="#struct-476572"/>
              <affiliation ref="#struct-300122"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Chouki</forename>
                <surname>Chenaf</surname>
              </persName>
              <idno type="halauthorid">1165114-0</idno>
              <affiliation ref="#struct-300144"/>
              <affiliation ref="#struct-1063704"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jessica</forename>
                <surname>Delorme</surname>
              </persName>
              <idno type="halauthorid">1459817-0</idno>
              <affiliation ref="#struct-300144"/>
              <affiliation ref="#struct-1063704"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nicolas</forename>
                <surname>Kerckhove</surname>
              </persName>
              <email type="md5">ba7f870c2cc18ea214610d7f1dc7eb1c</email>
              <email type="domain">chu-clermontferrand.fr</email>
              <idno type="idhal" notation="string">nkerckhove</idno>
              <idno type="idhal" notation="numeric">1081265</idno>
              <idno type="halauthorid" notation="string">1069529-1081265</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-2223-1240</idno>
              <idno type="VIAF">https://viaf.org/viaf/314922326</idno>
              <idno type="IDREF">https://www.idref.fr/183513592</idno>
              <affiliation ref="#struct-300144"/>
              <affiliation ref="#struct-1063704"/>
              <affiliation ref="#struct-1089760"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Antoine</forename>
                <surname>Pariente</surname>
              </persName>
              <email type="md5">398914e7e38a952a1ef1ec587ff793c8</email>
              <email type="domain">pharmaco.u-bordeaux2.fr</email>
              <idno type="idhal" notation="numeric">1125076</idno>
              <idno type="halauthorid" notation="string">611699-1125076</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-7873-5483</idno>
              <affiliation ref="#struct-476572"/>
              <affiliation ref="#struct-300122"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Marie</forename>
                <surname>Daubech-Tournier</surname>
              </persName>
              <idno type="halauthorid">2331198-0</idno>
              <affiliation ref="#struct-476572"/>
              <affiliation ref="#struct-300538"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nicolas</forename>
                <surname>Authier</surname>
              </persName>
              <email type="md5">a2baa6830de9537e8610b70861a7a916</email>
              <email type="domain">chu-clermontferrand.fr</email>
              <idno type="idhal" notation="string">nicolasauthier</idno>
              <idno type="idhal" notation="numeric">1320534</idno>
              <idno type="halauthorid" notation="string">658850-1320534</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-1236-0383</idno>
              <affiliation ref="#struct-300144"/>
              <affiliation ref="#struct-1063704"/>
              <affiliation ref="#struct-1089760"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Oskar</forename>
                <surname>Admin</surname>
              </persName>
              <email type="md5">d49c5a880544a575d14059bbcdef4ae8</email>
              <email type="domain">oskar-bordeaux.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2022-10-14 15:09:33</date>
              <date type="whenModified">2026-04-25 09:24:34</date>
              <date type="whenReleased">2022-10-17 10:50:44</date>
              <date type="whenProduced">2022-06-30</date>
              <date type="whenEndEmbargoed">2022-10-14</date>
              <ref type="file" target="https://hal.science/hal-03815296v1/document">
                <date notBefore="2022-10-14"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://hal.science/hal-03815296v1/file/BPH_FP_2022_Bertin.pdf" id="file-3815296-3334917">
                <date notBefore="2022-10-14"/>
              </ref>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282723"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="851509">
                <persName>
                  <forename>Oskar</forename>
                  <surname>Admin</surname>
                </persName>
                <email type="md5">d49c5a880544a575d14059bbcdef4ae8</email>
                <email type="domain">oskar-bordeaux.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03815296</idno>
            <idno type="halUri">https://hal.science/hal-03815296</idno>
            <idno type="halBibtex">bertin:hal-03815296</idno>
            <idno type="halRefHtml">&lt;i&gt;Frontiers in Psychiatry&lt;/i&gt;, 2022, 13, &lt;a target="_blank" href="https://dx.doi.org/10.3389/fpsyt.2022.893590"&gt;&amp;#x27E8;10.3389/fpsyt.2022.893590&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Frontiers in Psychiatry, 2022, 13, &amp;#x27E8;10.3389/fpsyt.2022.893590&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 - Attribution<ref corresp="#file-3815296-3334917"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="PRES_CLERMONT">Université de Clermont</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" corresp="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="ND" corresp="PRES_CLERMONT">Neuro-Dol</idno>
            <idno type="stamp" n="ACL-SVSAE" corresp="PRES_CLERMONT">ACL en SVSAE</idno>
            <idno type="stamp" n="CHU-CLERMONTFERRAND">CHU DE CLERMONT FERRAND</idno>
            <idno type="stamp" n="U1219" corresp="INSERM">Bordeaux Population Health</idno>
            <idno type="stamp" n="TEST3-HALCNRS">TEST3-HALCNRS</idno>
            <idno type="stamp" n="UNIVERSITE-BORDEAUX">Université de Bordeaux</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Celian</forename>
                    <surname>Bertin</surname>
                  </persName>
                  <email type="md5">114ac354fd081f0b5b286d44aed92b11</email>
                  <email type="domain">chu-clermontferrand.fr</email>
                  <idno type="idhal" notation="string">celian-bertin</idno>
                  <idno type="idhal" notation="numeric">1318562</idno>
                  <idno type="halauthorid" notation="string">1459818-1318562</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-2393-7061</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=MifamIcAAAAJ</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/AAG-6322-2021</idno>
                  <idno type="IDREF">https://www.idref.fr/24512893X</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/AAG-6322-2021</idno>
                  <affiliation ref="#struct-300144"/>
                  <affiliation ref="#struct-1063704"/>
                  <affiliation ref="#struct-1089760"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Julien</forename>
                    <surname>Bezin</surname>
                  </persName>
                  <email type="md5">8f0884978d348bd621798a5caf01e699</email>
                  <email type="domain">u-bordeaux.fr</email>
                  <idno type="idhal" notation="numeric">1670226</idno>
                  <idno type="halauthorid" notation="string">1176113-1670226</idno>
                  <idno type="IDREF">https://www.idref.fr/181595710</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-2568-1928</idno>
                  <affiliation ref="#struct-476572"/>
                  <affiliation ref="#struct-300122"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Chouki</forename>
                    <surname>Chenaf</surname>
                  </persName>
                  <idno type="halauthorid">1165114-0</idno>
                  <affiliation ref="#struct-300144"/>
                  <affiliation ref="#struct-1063704"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jessica</forename>
                    <surname>Delorme</surname>
                  </persName>
                  <idno type="halauthorid">1459817-0</idno>
                  <affiliation ref="#struct-300144"/>
                  <affiliation ref="#struct-1063704"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nicolas</forename>
                    <surname>Kerckhove</surname>
                  </persName>
                  <email type="md5">ba7f870c2cc18ea214610d7f1dc7eb1c</email>
                  <email type="domain">chu-clermontferrand.fr</email>
                  <idno type="idhal" notation="string">nkerckhove</idno>
                  <idno type="idhal" notation="numeric">1081265</idno>
                  <idno type="halauthorid" notation="string">1069529-1081265</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-2223-1240</idno>
                  <idno type="VIAF">https://viaf.org/viaf/314922326</idno>
                  <idno type="IDREF">https://www.idref.fr/183513592</idno>
                  <affiliation ref="#struct-300144"/>
                  <affiliation ref="#struct-1063704"/>
                  <affiliation ref="#struct-1089760"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Antoine</forename>
                    <surname>Pariente</surname>
                  </persName>
                  <email type="md5">398914e7e38a952a1ef1ec587ff793c8</email>
                  <email type="domain">pharmaco.u-bordeaux2.fr</email>
                  <idno type="idhal" notation="numeric">1125076</idno>
                  <idno type="halauthorid" notation="string">611699-1125076</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-7873-5483</idno>
                  <affiliation ref="#struct-476572"/>
                  <affiliation ref="#struct-300122"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Marie</forename>
                    <surname>Daubech-Tournier</surname>
                  </persName>
                  <idno type="halauthorid">2331198-0</idno>
                  <affiliation ref="#struct-476572"/>
                  <affiliation ref="#struct-300538"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nicolas</forename>
                    <surname>Authier</surname>
                  </persName>
                  <email type="md5">a2baa6830de9537e8610b70861a7a916</email>
                  <email type="domain">chu-clermontferrand.fr</email>
                  <idno type="idhal" notation="string">nicolasauthier</idno>
                  <idno type="idhal" notation="numeric">1320534</idno>
                  <idno type="halauthorid" notation="string">658850-1320534</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-1236-0383</idno>
                  <affiliation ref="#struct-300144"/>
                  <affiliation ref="#struct-1063704"/>
                  <affiliation ref="#struct-1089760"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">90338</idno>
                <idno type="issn">1664-0640</idno>
                <title level="j">Frontiers in Psychiatry</title>
                <imprint>
                  <publisher>Frontiers</publisher>
                  <biblScope unit="volume">13</biblScope>
                  <date type="datePub">2022-06-30</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3389/fpsyt.2022.893590</idno>
              <idno type="pubmed">35845444</idno>
              <idno type="pubmedcentral">PMC9282723</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">Morphine dependence</term>
                <term xml:lang="en">Prescription medication misuse</term>
                <term xml:lang="en">Healthcare database</term>
                <term xml:lang="en">Opioid maintenance treatment</term>
                <term xml:lang="en">Overdose</term>
                <term xml:lang="en">Substance use disorder</term>
                <term xml:lang="en">Morphine</term>
                <term xml:lang="en">Opioid</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BACKGROUND: National health monitoring agencies have reported the alternative use of morphine sulfate painkiller for maintenance treatment of opioid use disorder (OUD), associated with a potential increase in overdose risk. OBJECTIVES: This study sought to assess the prevalence of regular and occasional legally prescribed morphine use in patients treated for OUD and compare their characteristics to those of patients receiving conventional opioid maintenance treatment (OMT), buprenorphine or methadone. Then, we assessed the factors associated with opioid overdose risk. METHODS: Data were extracted from the French national healthcare system database, covering the entire population in 2015. Diagnosis associated with hospital discharge and long-term disease codes were extracted to select the population and identify outcomes and covariates. OUD non-chronic pain patients were divided into regular (≤35 days between dispensing and ≥3 months of continuous treatment duration) morphine users, and occasional users. Their sociodemographic and health characteristics were compared to OMT controls. A multivariate logistic regression model was performed to determine factors associated with opioid overdose. RESULTS: In patients treated for OUD, 2,237 (2.2%) morphine users (1,288 regular and 949 occasional), 64,578 (63.7%) buprenorphine and 34,638 (34.1%) methadone controls were included. The prevalence of regular morphine use among patients treated for OUD regularly receiving an opioid was 1.3%. Compared to users who receive morphine regularly, occasional users had an increased risk of overdose [OR = 2.2 (1.5-3.3)], while the risk was reduced in the buprenorphine group [OR = 0.5 (0.4-0.7)] and not significantly different for methadone [OR = 1.0 (0.7-1.4)]. Other overdose risk factors were low-income, comorbidity, i.e., psychiatric conditions, alcohol use disorder or complications related to intravenous drug use, and coprescription with benzodiazepines or pregabalin. These factors were more frequent in morphine groups. CONCLUSIONS: Patients that were prescribed oral morphine represented a small minority of the treated for OUD. The poorer health condition affected by numerous comorbidities and higher risk of opioid overdose in patients treated with oral morphine compared with OMT controls points toward the need to better supervise the practices of these patients, to strengthen multidisciplinary care and risk reduction measures.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="regroupinstitution" xml:id="struct-300144" status="VALID">
          <idno type="IdRef">026606836</idno>
          <idno type="ISNI">0000000406394151</idno>
          <idno type="ROR">https://ror.org/02tcf7a68</idno>
          <orgName>CHU Clermont-Ferrand</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-clermontferrand.fr/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-1063704" status="VALID">
          <idno type="IdRef">195779916</idno>
          <idno type="RNSR">201220182P</idno>
          <orgName>Neuro-Dol</orgName>
          <orgName type="acronym">Neuro-Dol</orgName>
          <date type="start">2021-01-01</date>
          <desc>
            <address>
              <addrLine>UFR Médecine Pharmacie, TSA 50400, 28 Place Henri Dunant, 63001 Clermont-Ferrand // Faculté de Chirurgie Dentaire, 2 Rue de Braga, 63100 Clermont-Ferrand</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://neurodol.uca.fr/</ref>
          </desc>
          <listRelation>
            <relation name="U1107" active="#struct-303623" type="direct"/>
            <relation name="UMR1107" active="#struct-1063463" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-1089760" status="VALID">
          <orgName>Institut Analgesia</orgName>
          <date type="start">2016-01-01</date>
          <desc>
            <address>
              <addrLine>Fondation Institut ANALGESIA Faculté de Médecine 28, Place Henri Dunant 63000 Clermont-Ferrand</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.institut-analgesia.org</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-476572" status="VALID">
          <idno type="IdRef">197398162</idno>
          <idno type="RNSR">201622170H</idno>
          <idno type="ROR">https://ror.org/00xzzba89</idno>
          <orgName>Bordeaux population health</orgName>
          <orgName type="acronym">BPH</orgName>
          <desc>
            <address>
              <addrLine>Université de Bordeaux - Case 11 - 146 rue Léo Saignat  33076 Bordeaux cedex</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-259761" type="direct"/>
            <relation active="#struct-302259" type="direct"/>
            <relation name="U1219" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300122" status="VALID">
          <idno type="IdRef">028228421</idno>
          <idno type="ROR">https://ror.org/01hq89f96</idno>
          <orgName>Centre Hospitalier Universitaire de Bordeaux</orgName>
          <orgName type="acronym">CHU Bordeaux</orgName>
          <desc>
            <address>
              <addrLine>12 rue Dubernat 33400 Talence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chu-bordeaux.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300538" status="VALID">
          <orgName>Centre hospitalier Charles Perrens [Bordeaux]</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.ch-perrens.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-1063463" status="VALID">
          <idno type="IdRef">252404955</idno>
          <idno type="ISNI">0000000115480420</idno>
          <idno type="ROR">https://ror.org/01a8ajp46</idno>
          <orgName>Université Clermont Auvergne</orgName>
          <orgName type="acronym">UCA</orgName>
          <date type="start">2021-01-01</date>
          <desc>
            <address>
              <addrLine>49, bd François-Mitterrand / CS 60032 / 63001 Clermont-Ferrand Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.uca.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-259761" status="VALID">
          <idno type="IdRef">175206562</idno>
          <idno type="ROR">https://ror.org/057qpr032</idno>
          <orgName>Université de Bordeaux</orgName>
          <orgName type="acronym">UB</orgName>
          <desc>
            <address>
              <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-bordeaux.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-302259" status="VALID">
          <orgName>Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>